Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Sell
50
NHI Quote, Financials, Valuation and Earnings
Last price:
$84.87
Seasonality move
:
0.6%
Day range:
$85.45 - $87.19
52-week range:
$66.41 - $91.38
Dividend yield:
4.2%
P/E ratio:
28.75x
P/S ratio:
10.78x
P/B ratio:
2.72x
Volume:
305.2K
Avg. volume:
303.8K
1-year change:
18.28%
Market cap:
$4.1B
Revenue:
$378.5M
EPS (TTM):
$3.02
Analysts' Opinion
-
Consensus RatingNational Health Investors, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 5 Buy ratings, 3 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $87.63, National Health Investors, Inc. has an estimated upside of 1.01% from its current price of $86.75.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $77.00 representing 11.24% downside risk from its current price of $86.75.
Fair Value
-
According to the consensus of 8 analysts, National Health Investors, Inc. has 1.01% upside to fair value with a price target of $87.63 per share.
NHI vs. S&P 500
-
Over the past 5 trading days, National Health Investors, Inc. has underperformed the S&P 500 by -1.18% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
National Health Investors, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
National Health Investors, Inc. has grown year-over-year revenues for 7 quarters straight. In the most recent quarter National Health Investors, Inc. reported revenues of $106.5M.
Earnings Growth
-
National Health Investors, Inc. earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter National Health Investors, Inc. reported earnings per share of $0.80.
Enterprise value:
5.3B
EV / Invested capital:
1.96x
Price / LTM sales:
10.78x
EV / EBIT:
27.18x
EV / Revenue:
13.99x
PEG ratio (5yr expected):
2.90x
EV / Free cash flow:
24.04x
Price / Operating cash flow:
18.53x
Enterprise value / EBITDA:
19.00x
Gross Profit (TTM):
$222.8M
Return On Assets:
5.18%
Net Income Margin (TTM):
37.19%
Return On Equity:
9.56%
Return On Invested Capital:
5.35%
Operating Margin:
47.16%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2024-12-31 | 2025-12-31 | |
| Income Statement | ||||||
| Revenue | $322.4M | $338.1M | $378.5M | $86.5M | $106.5M | |
| Gross Profit | $198.8M | $210.3M | $222.8M | $53.5M | $58.2M | |
| Operating Income | $179M | $189.5M | $194.8M | $48M | $50.2M | |
| EBITDA | $251.5M | $263.9M | $278.7M | $67.4M | $72.6M | |
| Diluted EPS | $3.13 | $3.12 | $3.02 | $0.95 | $0.80 | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $500M | $372.6M | $357.3M | $392.5M | $313.8M | |
| Total Assets | $2.8B | $2.5B | $2.5B | $2.6B | $2.8B | |
| Current Liabilities | $148.7M | $480.4M | $148.8M | $404.7M | $213.2M | |
| Total Liabilities | $1.3B | $1.2B | $1.2B | $1.2B | $1.3B | |
| Total Equity | $1.5B | $1.3B | $1.3B | $1.4B | $1.5B | |
| Total Debt | $1.2B | $1.1B | $1.1B | $1.1B | $1.2B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2024-12-31 | 2025-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $187.5M | $208.2M | $240.2M | $57.6M | $69.4M | |
| Cash From Investing | -$11.7M | -$191.5M | -$271.1M | -$160.1M | -$187.2M | |
| Cash From Financing | -$172.7M | -$14.7M | $24M | $111.3M | $55.9M | |
| Free Cash Flow | $179.8M | $192.4M | $220.3M | $51.6M | $59.3M | |
NHI
Sector
Market Cap
$4.1B
$926.4M
Price % of 52-Week High
94.93%
89.69%
Dividend Yield
4.2%
2.32%
Shareholder Yield
-0.38%
3.4%
1-Year Price Total Return
18.29%
--
Beta (5-Year)
0.648
0.574
Dividend yield:
4.2%
Annualized payout:
$3.64
Payout ratio:
115.58%
Growth streak:
1 years
Technicals
8-day SMA
Sell
Level
$87.74
200-day SMA
Buy
Level
$76.65
Bollinger Bands (100)
Buy
Level
74.67 - 83.65
Chaikin Money Flow
Buy
Level
49.9M
20-day SMA
Sell
Level
$87.01
Relative Strength Index (RSI14)
Buy
Level
53.64
ADX Line
Sell
Level
26.62
Williams %R
Neutral
Level
-60.0519
50-day SMA
Buy
Level
$81.86
MACD (12, 26)
Buy
Level
1.58
25-day Aroon Oscillator
Buy
Level
52
On Balance Volume
Neutral
Level
47.7M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (1.9439)
Buy
CA Score
(Annual)
Level (0.0685)
Buy
Beneish M-Score
(Annual)
Level (-3.2223)
Buy
Momentum Score
Level (7)
Buy
Ohlson Score
Level (-0.5362)
Buy
Piotroski F Score
(Annual)
Level (7)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (7)
Revenue Forecast
Earnings per Share Forecast
Company Profile
National Health Investors, Inc. engages in the sale-leaseback, joint-venture, mortgage, and mezzanine financing of senior housing and medical investments. It operates through the Real Estate Investments and Senior Housing Operating Portfolio (SHOP) segments. The Real Estate Investments segment includes real estate investments and lease, mortgage, and other notes receivables in independent living facilities. The SHOP segment is involved in two ventures that own the operations of independent living facilities. The company was founded by W. Andrew Adams in 1991 and is headquartered in Murfreesboro, TN.
Stock Forecast FAQ
In the current month, NHI has received 5 Buy ratings 3 Hold ratings, and 0 Sell ratings. The NHI average analyst price target in the past 3 months is $87.63.
-
Where Will National Health Investors, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that National Health Investors, Inc. share price will rise to $87.63 per share over the next 12 months.
-
What Do Analysts Say About National Health Investors, Inc.?
Analysts are divided on their view about National Health Investors, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that National Health Investors, Inc. is a Sell and believe this share price will drop from its current level to $77.00.
-
What Is National Health Investors, Inc.'s Price Target?
The price target for National Health Investors, Inc. over the next 1-year time period is forecast to be $87.63 according to 8 Wall Street analysts, 5 of them rate the stock a Buy, 0 rate the stock a Sell, and 3 analysts rate the stock a Hold.
-
Is NHI A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for National Health Investors, Inc. is a Buy. 5 of 8 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of NHI?
You can purchase shares of National Health Investors, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase National Health Investors, Inc. shares.
-
What Is The National Health Investors, Inc. Share Price Today?
National Health Investors, Inc. was last trading at $84.87 per share. This represents the most recent stock quote for National Health Investors, Inc.. Yesterday, National Health Investors, Inc. closed at $86.75 per share.
-
How To Buy National Health Investors, Inc. Stock Online?
In order to purchase National Health Investors, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get NHI Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
NHI
Sector
P/E ratio
28.75x
18.17x
PEG ratio
2.90x
0.05x
P/B ratio
2.72x
0.83x
Price / LTM sales
10.78x
3.20x
Growth Metrics
NHI
Sector
Revenue growth
23.21%
2.38%
Earnings growth
-16.31%
-2.77%
Revenue (5-year growth)
3.07%
4.15%
Earnings forecast
$0.80
$0.13
Profitability
NHI
Sector
Profitability FY 2025
$222.8M
$154.5M
Return on invested capital
5.35%
1.75%
Return on assets
5.18%
1.59%
Return on equity
9.56%
3.38%
Earnings Date
Last Earnings Date
Feb
26
Next Earnings Date
May
4
Estimated Next Earnings Date
May
28
Balance Sheet
NHI
Sector
Total cash
$19.6M
$68.6M
Short term investments
--
$12.4M
Total assets
$2.8B
$3B
Long term debt
$1.2B
$293.6M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Sell
47
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 37x
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 35x
Sell
34
Is GOOGL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 28x
Alerts
Sell
46
ZD alert for Mar 4
Ziff Davis, Inc. [ZD] is up 3.64% over the past day.
Buy
54
KORU alert for Mar 4
Direxion Daily MSCI South Korea Bull 3X Shares [KORU] is up 5.43% over the past day.
Sell
40
PSIX alert for Mar 4
Power Solutions International, Inc. [PSIX] is down 1.4% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
